MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases

Stock Information for MeiraGTx Holdings plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MeiraGTx Holdings plc

MeiraGTx Reports Full Year 2018 Financial Results
MeiraGTx to Present at the Barclays Global Healthcare Conference
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
MeiraGTx Appoints Martin Indyk, Ph.D. to Board of Directors
MeiraGTx to Present at the BIO CEO & Investor Conference
Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
MeiraGTx to Present at the 37th Annual J.P. Morgan Healthcare Conference
MeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinson's Disease

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.